Exclusive

Publication

Byline

Cipla expects US sales ramp-up in FY27, maintains full year guidance

New Delhi, July 23 -- Cipla, which posted its financial results for the June quarter on Thursday, saw its profits dip 39% over softer US sales. However, the company expects sequential sales momentum i... Read More


Trump threatens 200% tariffs on generic drugs in 2028, wants manufacturing to move to US

New Delhi, July 22 -- US President Donald Trump has announced a phased tariff plan on imported generic medicines that will escalate duties to 200% by 2029 if foreign manufacturers-led by India's multi... Read More


Pharma Q1FY27 preview: Domestic strength to offset muted US growth

New Delhi, July 21 -- The Indian pharmaceutical sector is expected to post healthy revenue growth in the April-June quarter (Q1FY27), supported by domestic demand and acquisitions, but the US business... Read More


Quick pharma startup Plazza to expand store network with $15 mn funding

Mumbai, July 20 -- Quick medicine delivery platform Plazza has raised $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners, with participation from ex... Read More


HealthKois eyes biotech bets as new drug pipelines expand

New Delhi, July 15 -- Venture capital (VC) firm HealthKois is sharpening its focus on life sciences innovation as it evaluates investment opportunities for its $300-million third fund, amid a growing ... Read More


Mylan launches block deal to sell minority stake in Biocon for up to $363 million

New Delhi, July 13 -- Mylan Inc, an arm of US healthcare major Viatris, has launched a block deal to sell its minority stake in Biocon Ltd of up to $363 million ( Rs.34.81 billion), according to a ter... Read More


Mint Explainer | Why are generic weight loss drugs losing steam?

New Delhi, July 13 -- After an initial surge, generic semaglutide brands have begun to plateau, according to monthly sales data. With demand steadying, industry watchers expect the June trend to conti... Read More


Dr Reddy's delays semaglutide supplies due to API issue

MUMBAI, July 9 -- Dr Reddy's Laboratories' plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and we... Read More


Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection

Mumbai, July 7 -- Strand Life Sciences, a subsidiary of Reliance Industries Ltd, on Tuesday said it has secured an Indian patent for an integrated platform that uses DNA analysis from a blood sample t... Read More


Age Care Labs raises Rs.85 crore to scale senior care services

New Delhi, July 2 -- Age Care Labs has raised Rs.85 crore as the eldercare startup seeks to expand its offerings and tap India's growing elderly population. The latest investment is part of a larger ... Read More